|
|
Date of Report (Date of earliest event reported)
|
March 8, 2018
|
AquaBounty Technologies, Inc.
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
001-36426
|
04-3156167
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
2 Mill & Main Place, Suite 395, Maynard, Massachusetts
|
01754
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code
|
978-648-6000
|
|
(Former name or former address, if changed since last report.)
|
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press release issued by AquaBounty Technologies, Inc. on March 8, 2018, furnished herewith.
|
|
|
AquaBounty Technologies, Inc.
|
|
|
(Registrant)
|
March 8, 2018
|
|
/s/ David A. Frank
|
|
|
David A. Frank
|
|
|
Chief Financial Officer
|
Exhibit No.
|
|
Description
|
|
•
|
Made first sales of AquAdvantage
®
Salmon, selling five tons of fillets in Canada;
|
•
|
Established first commercial-scale production facility in the United States through the purchase of certain assets of the Bell Fish Company LLC farm site in Albany, Indiana;
|
•
|
Received provincial approval from the Prince Edward Island regulatory authorities to construct a broodstock facility and a grow-out facility on the Company’s Rollo Bay site;
|
•
|
Completed renovations to the Company’s R&D building on its Rollo Bay site;
|
•
|
Completed a $25.0 million equity subscription with Intrexon Corporation in conjunction with the Company’s listing of its common shares on the NASDAQ Capital Market; and
|
•
|
Net loss for the year increased to $9.3 million (2016: $8.5 million).
|
|
As of
|
|||
|
December 31,
|
|||
|
2017
|
2016
|
||
Assets
|
|
|
|
|
Current assets:
|
|
|
|
|
Cash and cash equivalents
|
$
|
492,861
|
$
|
3,324,609
|
Certificate of deposit
|
|
13,422
|
|
10,666
|
Other receivables
|
|
183,926
|
|
164,743
|
Inventory
|
|
172,363
|
|
0
|
Prepaid expenses and other assets
|
|
527,322
|
|
72,983
|
Total current assets
|
|
1,389,894
|
|
3,573,001
|
|
|
|
|
|
Property, plant and equipment, net
|
|
21,802,976
|
|
1,723,707
|
Definite lived intangible assets, net
|
|
184,995
|
|
198,698
|
Indefinite lived intangible assets
|
|
191,800
|
|
191,800
|
Other assets
|
|
162,093
|
|
21,628
|
Total assets
|
$
|
23,731,758
|
$
|
5,708,834
|
|
|
|
|
|
Liabilities and stockholders' equity
|
|
|
|
|
Current liabilities:
|
|
|
|
|
Accounts payable and accrued liabilities
|
$
|
2,666,855
|
$
|
1,017,851
|
Current debt
|
|
49,794
|
|
17,913
|
Total current liabilities
|
|
2,716,649
|
|
1,035,764
|
|
|
|
|
|
Long-term debt
|
|
3,034,420
|
|
2,645,015
|
Total liabilities
|
|
5,751,069
|
|
3,680,779
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
Stockholders' equity:
|
|
|
|
|
Common stock, $0.001 par value, 200,000,000 shares authorized;
|
|
|
|
|
8,895,094 (2016: 6,463,936) shares outstanding
|
|
8,895
|
|
6,464
|
Additional paid-in capital
|
|
126,718,186
|
|
101,581,724
|
Accumulated other comprehensive loss
|
|
(213,884)
|
|
(286,272)
|
Accumulated deficit
|
|
(108,532,508)
|
|
(99,273,861)
|
Total stockholders' equity
|
|
17,980,689
|
|
2,028,055
|
|
|
|
|
|
Total liabilities and stockholders' equity
|
$
|
23,731,758
|
$
|
5,708,834
|
|
Years ended December 31,
|
||||||
|
2017
|
2016
|
2015
|
||||
Revenues
|
|
|
|
|
|||
Product revenues
|
$
|
53,278
|
$
|
0
|
$
|
0
|
|
|
|
|
|
|
|
|
|
Costs and expenses
|
|
|
|
|
|
|
|
Product costs
|
|
50,777
|
|
0
|
|
0
|
|
Sales and marketing
|
|
799,009
|
|
860,365
|
|
993,706
|
|
Research and development
|
|
3,371,767
|
|
3,429,400
|
|
3,338,411
|
|
General and administrative
|
|
5,063,824
|
|
3,775,289
|
|
2,696,369
|
|
Total costs and expenses
|
|
9,285,377
|
|
8,065,054
|
|
7,028,486
|
|
|
|
|
|
|
|
|
|
Operating loss
|
|
(9,232,099)
|
|
(8,065,054)
|
|
(7,028,486)
|
|
|
|
|
|
|
|
|
|
Other income (expense)
|
|
|
|
|
|
|
|
Interest expense
|
|
(21,537)
|
|
(402,554)
|
|
(10)
|
|
Gain on disposal of equipment
|
|
941
|
|
2,861
|
|
1,912
|
|
Other income (expense), net
|
|
(5,952)
|
|
(5,914)
|
|
(4,928)
|
|
Total other income (expense)
|
|
(26,548)
|
|
(405,607)
|
|
(3,026)
|
|
|
|
|
|
|
|
|
|
Net loss
|
$
|
(9,258,647)
|
$
|
(8,470,661)
|
$
|
(7,031,512)
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
Foreign currency translation gain (loss)
|
|
72,388
|
|
(59,840)
|
|
228,740
|
|
Total other comprehensive income (loss)
|
|
72,388
|
|
(59,840)
|
|
228,740
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
$
|
(9,186,259)
|
$
|
(8,530,501)
|
$
|
(6,802,772)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted net loss per share
|
$
|
(1.06)
|
$
|
(1.60)
|
$
|
(1.40)
|
|
Weighted average number of common shares -
|
|
|
|
|
|
|
|
basic and diluted
|
|
8,772,494
|
|
5,303,114
|
|
5,037,368
|
|
Years ended December 31,
|
|||||
|
2017
|
2016
|
2015
|
|||
Operating activities
|
|
|
|
|
|
|
Net loss
|
$
|
(9,258,647)
|
$
|
(8,470,661)
|
$
|
(7,031,512)
|
Adjustment to reconcile net loss to net cash used in
|
|
|
|
|
|
|
operating activities:
|
|
|
|
|
|
|
Depreciation and amortization
|
|
184,946
|
|
153,996
|
|
105,952
|
Share-based compensation
|
|
122,134
|
|
218,294
|
|
237,822
|
Gain on disposal of equipment
|
|
(941)
|
|
(2,861)
|
|
(1,912)
|
Non-cash expense
|
|
0
|
|
395,833
|
|
0
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
Other receivables
|
|
(11,440)
|
|
(121,640)
|
|
(21,195)
|
Inventory
|
|
(169,991)
|
|
0
|
|
0
|
Prepaid expenses and other assets
|
|
(592,602)
|
|
38,054
|
|
(12,421)
|
Accounts payable and accrued liabilities
|
|
625,763
|
|
340,092
|
|
(25,032)
|
Net cash used in operating activities
|
|
(9,100,778)
|
|
(7,448,893)
|
|
(6,748,298)
|
|
|
|
|
|
|
|
Investing activities
|
|
|
|
|
|
|
Purchase of property, plant and equipment
|
|
(19,046,927)
|
|
(1,091,477)
|
|
(74,113)
|
Proceeds from sale of equipment
|
|
941
|
|
23,844
|
|
0
|
Payment of patent costs
|
|
0
|
|
(5,664)
|
|
(30,372)
|
Net cash used in investing activities
|
|
(19,045,986)
|
|
(1,073,297)
|
|
(104,485)
|
|
|
|
|
|
|
|
Financing activities
|
|
|
|
|
|
|
Proceeds from issuance of debt
|
|
256,807
|
|
547,142
|
|
44,004
|
Repayment of term debt
|
|
(35,812)
|
|
(6,268)
|
|
0
|
Proceeds from the issuance of convertible debt
|
|
0
|
|
10,000,000
|
|
0
|
Proceeds from the issuance of common stock, net
|
|
24,989,257
|
|
0
|
|
3,000,000
|
Proceeds from exercise of stock options
|
|
27,502
|
|
0
|
|
0
|
Net cash provided by financing activities
|
|
25,237,754
|
|
10,540,874
|
|
3,044,004
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
77,262
|
|
(7,496)
|
|
(41,062)
|
Net change in cash and cash equivalents
|
|
(2,831,748)
|
|
2,011,188
|
|
(3,849,841)
|
Cash and cash equivalents at beginning of period
|
|
3,324,609
|
|
1,313,421
|
|
5,163,262
|
Cash and cash equivalents at end of period
|
$
|
492,861
|
$
|
3,324,609
|
|
1,313,421
|
|
|
|
|
|
|
|
Supplemental cash flow information
|
|
|
|
|
|
|
Interest paid in cash
|
$
|
21,537
|
$
|
6,721
|
|
10
|
Conversion of convertible debt and accrued interest
|
$
|
0
|
$
|
10,395,833
|
|
0
|
Purchases of equipment included in accounts payable
|
$
|
1,036,240
|
$
|
50,132
|
|
0
|